Sorbinil

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSorbinil
Drug Alias Name索比尼尔sorbinilsorbinilo索白尼尔sorbinilum +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetes MellitusDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusDiabetic Retinopathy

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG